There's still hunger for 'blockbuster' biotech deals By: CNBC.com News August 25, 2014 at 10:58 AM EDT Roche's $8.3 billion deal for InterMune is one of the few this year that returns to the traditional model of big pharma buying smaller biotech. Read More >> Related Stocks: AbbVie Astrazeneca Plc ADR Bristol-Myers Squibb Johnson & Johnson Merck & Co Pfizer Rogers Corp Shire Plc Ads